Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TAP1 is an ATP-binding cassette (ABC) transporter protein that forms a heterodimer with TAP2 to create the TAP complex. This complex is located in the endoplasmic reticulum membrane and transports peptides derived from cytosolic proteins into the ER. These peptides are then loaded onto MHC class I molecules and presented on the cell surface, initiating an immune response. Mutations in TAP1 can lead to Bare Lymphocyte Syndrome Type I and may be associated with other autoimmune diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transporter 1, ATP Binding Cassette Subfamily B Member (TAP1).